Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02703220 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sleep Apnea in Elderly

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jul 31, 2026 → Jul 30, 2027
See other at-risk trials from VA Office of Research and Development

Record History

  1. Notable Primary completion pushed from Jul 31, 2026 to Jul 30, 2027 Completion pushed from Jul 31, 2026 to Dec 31, 2027 · Site contact updated · Eligibility criteria expanded, about 4 words · 1 morev20 Show 4 more changesShow less
    • Completion pushed from Jul 31, 2026 to Dec 31, 2027
    • Site contact updated
    • Eligibility criteria expanded, about 4 words
    • Study description expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  2. Minor Study Status, Referencesv19
  3. Notable Primary and study completion dates: Jul 1, 2025 to Jul 31, 2026 Site contact updatedv18 Show 1 more changeShow less
    • Site contact updated
  4. Notable Primary and study completion dates: Jun 30, 2024 to Jul 1, 2025 Site contact updated · Publications: 1 to 2v17 Show 2 more changesShow less
    • Site contact updated
    • Publications: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

  5. Notable Primary and study completion dates: Jun 30, 2023 to Jun 30, 2024 Site details revisedv16 Show 1 more changeShow less
    • Site details revised
Show 14 earlier versionsHide 14 earlier versions
  1. Notable Primary and study completion dates: Dec 30, 2022 to Jun 30, 2023v15
  2. Notable Primary and study completion dates: Dec 31, 2021 to Dec 30, 2022v14
  3. Notable Primary and study completion dates: Dec 31, 2020 to Dec 31, 2021v13
  4. Notable Primary completion date: Jun 10, 2020 to Dec 31, 2020 Completion date: Jul 10, 2020 to Dec 31, 2020v12 Show 1 more changeShow less
    • Completion date: Jul 10, 2020 to Dec 31, 2020
  5. Notable Primary completion date: Dec 2, 2019 to Jun 10, 2020 Completion date: Mar 31, 2020 to Jul 10, 2020 · Site contact updatedv11 Show 2 more changesShow less
    • Completion date: Mar 31, 2020 to Jul 10, 2020
    • Site contact updated
  6. Minor Completion date: Dec 30, 2019 to Mar 31, 2020v10
  7. Minor Primary completion date: Jun 30, 2019 to Dec 2, 2019 Completion date: Jun 30, 2019 to Dec 30, 2019v9 Show 1 more changeShow less
    • Completion date: Jun 30, 2019 to Dec 30, 2019
  8. Minor Re-verified, no change to tracked fieldsv8
  9. Minor Site contact updatedv7
  10. Minor Eligibility criteria shortened, about 7 words Study description expanded, about 11 wordsv6 Show 1 more changeShow less
    • Study description expanded, about 11 words

    See this version in full on ClinicalTrials.gov ↗

  11. Notable Phase: Not applicable to Phase 4v5
  12. Minor Primary and study completion dates: Jun 2019 to Jun 30, 2019 Start date: Jul 2015 to Jul 3, 2015v4 Show 1 more changeShow less
    • Start date: Jul 2015 to Jul 3, 2015
  13. Minor 2 versions Re-verified since Aug 5, 2016, no change to tracked fieldsv2-v3
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sleep-disordered breathing (SDB or sleep apnea) is very common among elderly Veterans and leads to increased morbidity and mortality in this population. The proposal aims to identity whether oxygen, finasteride and acetazolamide can be effective in reducing unstable breathing and eliminating sleep apnea in the elderly via different mechanisms. This proposal will enhance the investigators' understanding of the pathways that contribute to the development of sleep apnea in the elderly. The investigators expect that the results obtained from this study will positively impact the health of Veterans by identifying new treatment modalities for sleep apnea. A cumulative effect of the investigators' research will fulfill the long-term goal of improving the quality of life of elderly Veterans suffering from sleep apnea and its potential life-threatening complications.
Trial Details
NCT Number NCT02703220
Lead Sponsor VA Office of Research and Development
Conditions Sleep Apnea, Elderly Adults
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov